Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

NYCB closes $1 billion capital infusion deal, announces reverse stock split

Published 03/11/2024, 08:35 PM
Updated 03/11/2024, 10:10 PM
© Reuters. FILE PHOTO: A man walks past a closed branch of the New York Community Bank in New York City, U.S., January 31, 2024. REUTERS/Mike Segar/File Photo

(Reuters) -New York Community Bancorp (NASDAQ:CTBI) said on Monday it had closed the $1 billion capital infusion deal that was agreed last week with an investor group and plans to submit one-for-three reverse stock split of its common stock to shareholders.

Joseph Otting, former Comptroller of the Currency in the Donald Trump administration, was named NYCB's chief executive last week as part of a $1 billion capital injection from a group of investors that included former U.S. Treasury Secretary Steven Mnuchin.

The bank said on Monday it had added Otting, Mnuchin, Milton Berlinski and Allen Puwalski as the new directors of the board, while reducing the board strength to 10 members.

Shares of NYCB rose 5.8% to $3.44 in extended trading on Monday.

The lender said last week that it was seeing interest from non-bank bidders for some of its loans, and will outline a new business plan in April after the bank had slashed its dividend again and disclosed deposits fell 7%.

A surprise quarterly loss and a 70% reduction of its dividend in January hammered NYCB's stock, which came under pressure again in late February after it said it had found "material weakness" in internal controls and revised its loss to 10 times higher than earlier due to a goodwill impairment charge.

Investment firms Hudson (NYSE:HUD) Bay Capital, Reverence Capital Partners, Citadel Global Equities, some institutional investors and certain members of NYCB's management last week had agreed to participate in the equity investment.

NYCB said it plans to raise the funds through stocks and warrants and investors will own about 39.6% of the company on a fully-diluted basis after the latest fund raising.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Several Wall Street analysts have flagged concerns that the lender's turnaround will likely take a long time as profits remain under pressure from its efforts to boost reserves for potential bad loans in its commercial real estate portfolio.

Latest comments

Looks like this one was saved by infusion.
Reverse split buys them more room to dilute shareholders again when their liquidity begins to dry up. Good Luck!
You salty that you missed out on buying shares sub $3?
they reported a met loss of like 2 billing last quarter. How long will 1 billion last? A few months.. Dying bank, short it!
Q4 223 net loss of $260 million, with full year net income of $2.4 billion. expected to be profitable 2024. Nice try, though.
Hopefully dividend also get back as before...around 7%!!!
But that doesnt given a big turn around anytime soon. It can take as long as 3-4 Qs to into reasonal shape - on books. That too if grred from investors and management doesnt kick in.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.